Cargando…
Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II
Mucolipidosis type II (MLII) is a severe multi-systemic genetic disorder caused by missorting of lysosomal proteins and the subsequent lysosomal storage of undegraded macromolecules. Although affected children develop disabling skeletal abnormalities, their pathogenesis is not understood. Here we re...
Autores principales: | Kollmann, Katrin, Pestka, Jan Malte, Kühn, Sonja Christin, Schöne, Elisabeth, Schweizer, Michaela, Karkmann, Kathrin, Otomo, Takanobu, Catala-Lehnen, Philip, Failla, Antonio Virgilio, Marshall, Robert Percy, Krause, Matthias, Santer, Rene, Amling, Michael, Braulke, Thomas, Schinke, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914524/ https://www.ncbi.nlm.nih.gov/pubmed/24127423 http://dx.doi.org/10.1002/emmm.201302979 |
Ejemplares similares
-
Elevated Bone Turnover in an Infantile Patient with Mucolipidosis II; No Association with
Hyperparathyroidism
por: Otomo, Takanobu, et al.
Publicado: (2011) -
Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin
por: Albers, Joachim, et al.
Publicado: (2013) -
Mannose 6 phosphorylation of lysosomal enzymes controls B cell functions
por: Otomo, Takanobu, et al.
Publicado: (2015) -
Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III
por: Di Lorenzo, Giorgia, et al.
Publicado: (2021) -
Hip Morphology in Mucolipidosis Type II
por: Ammer, Luise Sophie, et al.
Publicado: (2020)